To further confirm whether ErbB4 mediated the anti‐obesity effects of central Nrg4, HFD‐fed mice received i.c.v. administration of an ErbB4 antagonist, AG‐1478, followed by central injection of rNrg4. This evidence concerns the gene ERBB4 and obesity due to melanocortin 4 receptor deficiency.